TY - JOUR
T1 - Unfavorable social determinants of health and mortality risk by cardiovascular disease status
T2 - Findings from a National Study of United States Adults
AU - Maqsood, Muhammad Haisum
AU - Nguyen, Ryan
AU - Chang, Ryan
AU - Kundi, Harun
AU - Hagan, Kobina
AU - Butt, Sara
AU - Titus, Anoop
AU - Hyder, Adnan A.
AU - Javed, Umair
AU - Al-Kindi, Sadeer
AU - Blaha, Michael J.
AU - Mossialos, Elias
AU - Nasir, Khurram
AU - Javed, Zulqarnain
N1 - Publisher Copyright:
© 2023 Elsevier Inc.
PY - 2024/1
Y1 - 2024/1
N2 - Background: The association between cumulative burden of unfavorable social determinants of health (SDoH) and all-cause mortality has not been assessed by atherosclerotic cardiovascular disease (ASCVD) status on a population level in the United States. Methods: We assessed the association between cumulative social disadvantage and all-cause mortality by ASCVD status in the National Health Interview Survey, linked to the National Death Index. Results: In models adjusted for established clinical risk factors, individuals experiencing the highest level of social disadvantage (SDoH-Q4) had over 1.5 (aHR = 1.55; 95%CI = 1.22, 1.96) and 2-fold (aHR = 2.21; 95% CI = 1.91, 2.56) fold increased risk of mortality relative to those with the most favorable social profile (SDoH-Q1), respectively for adults with and without ASCVD; those experiencing co-occurring ASCVD and high social disadvantage had up to four-fold higher risk of mortality (aHR = 3.81; 95%CI = 3.36, 4.32). Conclusions: These findings emphasize the importance of a healthcare model that prioritizes efforts to identify and address key social and environmental barriers to health and wellbeing, particularly in individuals experiencing the double jeopardy of clinical and social risk.
AB - Background: The association between cumulative burden of unfavorable social determinants of health (SDoH) and all-cause mortality has not been assessed by atherosclerotic cardiovascular disease (ASCVD) status on a population level in the United States. Methods: We assessed the association between cumulative social disadvantage and all-cause mortality by ASCVD status in the National Health Interview Survey, linked to the National Death Index. Results: In models adjusted for established clinical risk factors, individuals experiencing the highest level of social disadvantage (SDoH-Q4) had over 1.5 (aHR = 1.55; 95%CI = 1.22, 1.96) and 2-fold (aHR = 2.21; 95% CI = 1.91, 2.56) fold increased risk of mortality relative to those with the most favorable social profile (SDoH-Q1), respectively for adults with and without ASCVD; those experiencing co-occurring ASCVD and high social disadvantage had up to four-fold higher risk of mortality (aHR = 3.81; 95%CI = 3.36, 4.32). Conclusions: These findings emphasize the importance of a healthcare model that prioritizes efforts to identify and address key social and environmental barriers to health and wellbeing, particularly in individuals experiencing the double jeopardy of clinical and social risk.
UR - http://www.scopus.com/inward/record.url?scp=85179430190&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85179430190&partnerID=8YFLogxK
U2 - 10.1016/j.ahj.2023.10.006
DO - 10.1016/j.ahj.2023.10.006
M3 - Article
C2 - 38071003
AN - SCOPUS:85179430190
SN - 0002-8703
VL - 267
SP - 95
EP - 100
JO - American heart journal
JF - American heart journal
ER -